Andrew Waters appointed Chief Financial Officer

  • Published on 20th September 2023 by Stevenage Bioscience Catalyst

Andrew Waters has been appointed Chief Financial Officer of Stevenage Bioscience Catalyst. Andrew is a chartered accountant with over 25 years’ experience, mostly gained within the Life Sciences industry.  His career has included 16 years within GSK in a number of Finance positions as well as a series of CFO roles in both private and public companies.  Andrew has a Physics degree from Imperial College and qualified as a chartered accountant with Price Waterhouse.   

He has built up wide-ranging experience across start-ups, SMEs, PLC, fund raising, Manufacturing, Life Sciences and Buy & Build. Senior leadership posts have included Regional Finance Director, GSK; Co-founder and CFO of private-equity funded pharmaceutical and consumer healthcare start-up Infirst Healthcare and CFO of public life sciences company Venture Life Group plc.  

Andrew said: “The life sciences industry is very close to my heart and I am delighted to be joining SBC and working with Sally Ann and her team.”

We use cookies to improve our site experience. Press accept to agree to our Cookie Policy. If you decline, your information won’t be tracked when you visit this website. A single cookie will be used in your browser to remember your preference not to be tracked.